| 0 (0%) | 09-27 12:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 109.75 |
1-year : | 128.19 |
| Resists | First : | 93.97 |
Second : | 109.75 |
| Pivot price | 92.49 |
|||
| Supports | First : | 91.15 |
Second : | 89.41 |
| MAs | MA(5) : | 92.36 |
MA(20) : | 92.01 |
| MA(100) : | 89.44 |
MA(250) : | 83.97 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 37.3 |
D(3) : | 50.8 |
| RSI | RSI(14): 53.7 |
|||
| 52-week | High : | 93.97 | Low : | 72.33 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ESGD ] has closed above bottom band by 39.5%. Bollinger Bands are 53.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 92.35 - 92.91 | 92.91 - 93.45 |
| Low: | 90.55 - 91.22 | 91.22 - 91.86 |
| Close: | 91.28 - 92.26 | 92.26 - 93.2 |
Thu, 25 Sep 2025
Evaluating the Role of Stress Biomarkers in Predicting Equine Gastric Ulcers - thehorse.com
Wed, 27 Aug 2025
(PDF) Comparison of oral esomeprazole and oral omeprazole in the treatment of equine squamous gastric disease - researchgate.net
Thu, 17 Jul 2025
Asset Allocation Insights - Quarterly Report: June 2025 - Seeking Alpha
Fri, 02 Aug 2024
Vets Explore Magnesium Oxide’s Potential for Managing Ulcers in Horses - thehorse.com
Mon, 15 Jul 2024
Best ESG ETFs - Dr Wealth
Fri, 08 Mar 2024
Study Finds Commercial Beet Pulp/Alfalfa/Oat Mix Helpful For Equine Ulcers - Paulick Report
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|